The Effect of Intravenous Lidocaine or Ketamine on Interleukin-6 Levels in Patients Undergoing Colorectal Surgery for Cancer: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Patients undergoing open colorectal surgery were randomly divided into two groups: Intravenous Lidocaine (IV-Lido) vs Intravenous Ketamine (IV-Keta). For the IV-Lido group, patients received a loading dose of Lidocaine than a continuous infusion over twenty-four hours. For the IV-Keta goup, patients received a loading dose of Ketamine than a continuous injection of Ketamine over twenty-four hours. Plasma concentrations of Interleukin-6(IL-6) were measured preoperatively before anesthetic induction and at twenty-four hour post operatively.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• Patients aged 18 or older.

• American society of anesthesiologists' (ASA) physical status of I-III.

• Elective open colorectal surgery.

⁃ NON INCLUSION CRITERIA:

• Patients with contraindications to lidocaine or ketamine.

• Corticosteroid therapy within the last 6 months.

• History of immunosuppressive therapy.

• History of surgery in the last 3 months.

• Personal medical history of inflammatory bowel disease.

• Personal medical history of cardiac arrythmias or conduction disorders.

• Alcohol or drug abuse.

• Chronic use of opioids or benzodiazepines.

Locations
Other Locations
Tunisia
Tunisia
RECRUITING
Nabeul
Contact Information
Primary
BEN ALI MECHAAL, Professor
mechaal_benali@yahoo.fr
72100533
Backup
KTATA HIBA, Dr
Hibetallah.ktata@fmt.utm.tn
72100500
Time Frame
Start Date: 2023-10-01
Estimated Completion Date: 2025-11-30
Participants
Target number of participants: 50
Treatments
Experimental: IV-Lido
Intravenous Lidocaine dose loading than continuous infusion
Active_comparator: IV-Keta
Intravenous Ketamine dose loading than continuous infusion
Related Therapeutic Areas
Sponsors
Leads: University Tunis El Manar

This content was sourced from clinicaltrials.gov